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ROLE OF CCR3 IN AGING RHESUS MONKEY BRAIN 
YI BU 
ABSTRACT 
Each year, aging and age-related deficits in cognitive function affect larger 
population worldwide. Research on aging has focused on changes in gray matter and 
white matter with age. A quantitative analysis of magnetic resonance images from 
healthy subjects of 16-79 years showed a significant negative correlation between gray 
matter volume and age (Taki et al., 2004). In addition, age-related cognitive decline is 
reported to be associated with white matter changes such as myelin damage, a result of 
both the inability of microglia to clear out damaged myelin debris and oligodendrocyte to 
support remyelination. Eotaxin-1 (CCL11) belongs to a group of eosinophil-specific 
chemoattractant originally found in peripheral immune system mediating allergic 
inflammation, asthma and atopic dermatitis (Garcia-Zepeda et al., 1996; Spergel, 
Mizoguchi, Oettgen, Bhan, & Geha, 1999). Recently it has been reported to have 
endogenous sources in the CNS and to increase with age in cerebral spinal fluid (CSF) as 
well as periphery in blood plasma. While CCL11 has been identified to increase with age, 
injection of CCL11 inhibit neurogenesis in young mice, which is likely to be mediated by 
C-C chemokine receptor type 3 (CCR3). CCR3 is also the only receptor for CCL11 that 
is expressed by oligodendrocyte precursor cells (OPCs) and by activated microglia in 
mice, which means it may participate in the process of microglial phagocytosis and 
oligodendrocyte myelination. To investigate if CCR3 is an important factor in the normal 
aging brain and its potential role in these existing findings, immunohistochemistry, 
	
	 v 
stereology and densitometry were performed in the anterior cingulate cortex and 
cingulum from brain tissue of 4 young adults and 6 aged rhesus monkeys that were 
behaviorally tested previously to 1) demonstrate any association between CCR3 
expression level and age 2) characterize changes in CCR3 level in relation to cognitive 
impairment 3) identify cellular localization of CCR3.  We found a significant increase in 
amount of CCR3 cingulate cortex with age, which suggests its pro-disease effect in other 
pathways such as the interaction between CNS and T cell immune system. Although for 
aged group increase in CCR3+ cell density in white matter appeared insignificant, we 
found that CCR3 was expressed exclusively in OPCs but was absent in mature 
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Aging has become an increasingly significant issue around the world. It’s reported that 
the population aged 60 years or over has tripled since 1950, reaching 600 million in 2000 
and surpassed 700 million by 2006. Current projections suggests that the number will 
triple again in another 50 years (Mba, 2010). While the increasing proportion of the aged 
puts a higher demand on social and medical services, it also motivates researchers to 
investigate the effects of the aging process in the structure and function of the brain. 
Aging is accompanied by gradual loss of physical strength and dexterity as well as 
functional decline in the sensory and visceral organs and the immune system, among 
which age-related cognitive decline is known to occur in both neurodegenerative diseases 
and in normal aging. Alzheimer’s disease (AD) is the most devastating age-related 
dementia and involves progression of cognitive impairment (Walhovd et al., 2010). In 
contrast to traditional view that there is neuronal loss with advanced aging, a large 
number of recent studies are pointing to white matter (WM) pathology. A quantitative 
analysis of stereology data used autopsied subjects excluding those that died of  diseases 
that could affect CNS directly (e.g. cerebrovascular incidents) or indirectly (e.g. diabetes) 
and showed that only 10% of neocortical neurons are lost in autopsied humans from 10 to 
90 years old but there was a reduction of WM volume by 30% with age (Pakkenberg, 
1997). While white matter pathology is poorly understood, it is well known that myelin 
sheaths provide for isolation between neurons for controlled electric signal conduction as 
well as rapid, saltatory conduction. Our lab has shown that age-related increases in 
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myelin pathology play an important role in the pathogenesis of age-related cognitive 
decline (Bowley, Cabral, Rosene, & Peters, 2010)  
Although numerous studies use rodents as an animal model to study normal cognitive 
aging (NCA) because they are smaller, fast-reproducing and can be easily housed, non-
human primates (NHP) are a better model to investigate normal aging in humans in that 
not only are they phylogenetically closer to human and they do not develop AD in spite 
of Aβ deposits that are similar to that in human (Heuer, Rosen, Cintron, & Walker, 2012; 
Jucker, 2010). In this study, rhesus macaques (Macaca Mulatta) were used because they 
share similar maturation progress to humans, their brain anatomy resembles human brain 
and they naturally demonstrate age-related cognitive decline which can be assessed by 
cognitive tests similar to those administered on human. Rhesus monkeys age at about 
three times the rate of human’s with a maximum lifespan of ~40 years with puberty 
occurring at 2.5-4.5 years old (Colman et al., 2009). Therefore, in this study monkeys 
with age ranging from 6-9 years old were categorized as “young” whereas 26-30 years 
old grouped as “old”. 
Chemokines are a family of chemoattractant cytokines. They are small proteins that may 
be secreted or membrane-bound. Together with their receptors, they play a vital role in 
cell migration in response to a chemical gradient, a process known as chemotaxis. 
Originally found in the periphery, their primary functions include regulation of lymph 
organ development, T-cell differentiation and tumor cell metastasis but fairly recent 
studies have shown that they function in the central nervous system as neuromodulators. 
Specifically CCL11, also known as eotaxin-1, although previously found to act in 
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periphery, has been shown to be produced by choroid plexus epithelial cells in aged mice 
and is able to undergo bidirectional transport across the blood brain barrier (BBB) by 
either binding to cellular components in blood or by direct interaction with BBB. They 
are found in various brain regions including frontal cortex, hypothalamus, hippocampus, 
occipital cortex and cerebellum, suggesting direct function in the CNS (Erickson, 
Morofuji, Owen, & Banks, 2014). Furthermore CCL11 was observed to be increased in 
the brain and cerebral spinal fluid (CSF) in the dorsal lateral frontal cortex(DLFC) in 
human subjects with chronic traumatic encephalopathy (CTE) compared with 
Alzheimer’s disease patients and healthy controls. In healthy agers CCL11 level was 
reported to increase in the cerebral spinal fluid and blood plasma. It was also found that 
young mice exposed in an aged systemic environment have decreased synaptic plasticity, 
impaired conditional fear conditioning and spatial learning, suggesting CCL11’s role in 
adult neurogenesis during normal aging process (Villeda et al., 2010). 
CCR3 is one of the receptors that bind to CCL11 and it is known to be expressed by 
astrocytes, microglia and neurons(van der Meer, Ulrich, Gonźalez-Scarano, & Lavi, 
2000). Specifically microglia are a major target of HIV-1 infection and according to an 
early in vitro study, CCR3 along with CCR5 expressed by microglia were reported to 
promote efficient infection of CNS by HIV-1(He et al., 1997). A later study showed that 
mice lacking Apolipoprotein E(ApoE) demonstrated more neuron damage in CA3 region, 
greater microglial activation and a greater percentage of activated microglia expressing 
CCR3(DUAN et al., 2006). Other studies looking at oligodendrocytes in rats suggested a 
role for CCR3 in myelination process since among all the chemokine receptors only 
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CCR3 is expressed on oligodendrocyte precursor cells (OPCs) where it appears, in a 
concentration dependent manner, to mediate a functional increase in OPC proliferation, 
differentiation, and inhibition of migration when bound by CCL11 (Maysami et al., 2006) 
Our laboratory has previously proposed two mechanisms that may underlie myelin 
damage during normal cognitive aging. First, with age, oligodendrocytes may be 
compromised and therefore less capable of maintaining myelin or remyelinating after 
damage. Second, age-related microglial dysfunction may lead to inability of these 
resident macrophages in the brain to clear debris, damaged myelin byproduct may 
accumulate (Shobin Eli, 2018). Alternatively, gray matter volume was found to decline 
gradually with age beginning in early adulthood (Taki et al., 2004). Also taking into 
account recent findings in other animal models that neuronal, OPC and microglial 
expression of CCR3 play important roles in either neurodegenerative diseases or normal 
cognitive aging (NCA), the present study aims to investigate the association between 
CCR3 expression levels in neurons and glial cells and NCA processes, and tries to 











Brain tissue from 10 rhesus monkeys (five males and five females) was used in this 
study. Their age ranges from 6.2 to 29.6 years old. Monkeys were procured from the 
Emory University Yerkes National Primate Research Center (Atlanta, GA) and were 
housed individually under 12 hour light/dark cycle at the Laboratory Animal Science 
Center at the Boston University School of Medicine. Aged animals used for this aging 
study were brought in at old age after living in an open social colony and remained here 
until the end of life without experimental intervention. Both the Yerkes National Primate 
Research Center and the Boston University Laboratory Animal Science Center are 
accredited by the Association for the Assessment and Accreditation of Laboratory 
Animal Care. Prior to subject selection, health records were screened to exclude any 
confound diseases that could impact normal aging process by affecting brain tissue 
composition and behavior. 
Upon entry of this project, all monkeys were behaviorally tested on a battery of tests 
assessing learning, memory and executive function. The behavioral testing includes: 
Delayed Non-Matching to Sample (DNMS) testing learning and recognition memory, 
Delayed Recognition Span Task (DRST) looking at working memory span and the 
Category Set Shifting Task(CSST) assessing executive function (Herndon et al., 1997; 
Moore et al., 2007). Based on the principal component analysis (PCA) that includes three 
test scores – DNMS-acquisition, DNMS-120s delay and DRST-spatial condition, a 
weighted average of these combined scores is computed and converted into a z-score. 
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The stack of z-scores then yield a cognitive impairment index (CII) such that animals 
with CII of 1.0 or less are considered unimpaired, 1.0-2.0 standard deviation above the 
mean is considered mild impairment and scores above 2.0 reflect serious cognitive 
impairment (Moore et al., 2007). In this study ten rhesus monkey with various age and 
cognitive status are included: four young adults, three old cognitively impaired and three 
old unimpaired rhesus monkeys including both male and female.  
Table 1. Subject List. Details on subjects used for this study. 
 
Animal Gender Age CII Group by CII 
AM180 F 29.6 3.513 impaired 
AM181 F 27.5 5.89 impaired 
AM243 M 24.4 4.402 impaired 
AM188 F 6.5 0.364 spared 
AM275 F 27.8 1.598 spared 
AM284 M 25.4 1.465 spared 
AM301 M 28.4 1.14 spared 
AM205 M 6.2 0.079 spared 
AM227H M 7.8 0.361 spared 




At the conclusion of behavioral testing monkeys were given MRI scans and had blood 
and CSF collected before brain tissue collection.  
Fixation  
For brain tissue harvest monkeys were sedated with ketamine hydrochloride (10mg/mL, 
intramuscular) and then deeply anesthetized with sodium pentobarbital (25 mg/kg, 
intravenous) followed by transcardial perfusion with 4% paraformaldehyde solution in 
0.1M phosphate buffer (pH=7.4) at 37˚C. Some subjects were first perfused with 4˚C 
Krebs-Henseleit buffer (pH=7.4, a mixture of 6.4 mM Na2HPO4, 137Mm NaCl, 5 Mm 
glucose, 0.3Mm CaCl2, 1 Mm MgCl2; Sigma-Aldrich) before the paraformaldehyde 
perfusion step. This step not only flushes the brain vasculature but also rapidly cools 
down the tissue, limiting the extent of potential proteolysis resulting from anoxia. After 
perfusion, brains were removed intact, weighed and photographed and post-fixed for less 
than 24 hours. 
Tissue Processing 
After perfusion, brains were cryoprotected by immersion in 10% glycerol and 2% DMSO 
in 0.1M phosphate buffer for one to three days until the entire block sank. Then the block 
was transferred into solution with 20% glycerol and 2% DMSO followed by rapid 
freezing in -75˚C isopentane. This method has been used in the lab for decades and has 
been proven to generate the least amount of freezing artifact which is mostly ice crystals 
formed by the freezing process itself and might disrupt the integrity of tissue by 
displacing  the tissue structure (Rosene, Roy, & Davis, 1986). For brain cutting, the 
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frozen blocks were removed from the -80 ˚C freezer and fix on the stage of sliding 
microtome so that they were cut in entirety in the coronal plane. The blocks were 
maintained frozen by surrounding them with pulverized dry ice that was re-packed every 
15 to 20 minutes as needed. Each block was cut into 10 interrupted series of 30 µm 
frozen sections. 24 vials were prepared for each series and contained 15-20mL of 15% 
glycerol in phosphate buffer. During cutting, each section was collected and put into the 
corresponding vial so that each vial contained 6-8 sections that were about 7200µm from 
their immediately previous section and sections within a series were spaced at 300µm 
intervals. After cutting, all vials were moved to -80˚C freezer for long-term storage and 
would be picked out and thawed upon further processing.  
Immunohistochemistry 
Antibodies labeling CCR3, astrocytes, mature and immature oligodendrocytes and 
microglia were used to assess tissue.  
Oligodendrocytes: CC1 antibody is most commonly used to specifically detect mature 
oligodendrocyte cell bodies and it is marketed as anti-adenomatous polyposis coli (APC, 
a tumor suppressor protein) clone CC1. Although APC was originally found to be linked 
to colon cancer, it has been reported to have a high expression level in the adult brain 
(Ratan et al., 1994). It has been established that antibodies targeting the N-terminal 
peptide (like CC1) have light staining for astrocytes and an intense staining for 
oligodendrocytes, which owes to the cross-reactivity with an unrelated antigen 
(Brakeman, Gu, Wang, Dolin, & Baraban, 1999). CC1 is primarily used to identify 
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mature oligodendrocyte cell bodies but its state-specific expression patterns haven’t been 
fully characterized(Ness, Valentino, Mciver, & Goldberg, 2005). 
Oligodendrocyte precursor cells: NG2 antibody is directed against the NG2 chondroitin 
sulfate proteoglycan, therefore identifies early oligodendrocyte progenitors and adult 
oligodendrocyte progenitors(Ness et al., 2005). Oligodendrocyte precursors are first 
identified at embryonic day 12-14 (E12-14) by their expression of mRNA for the platelet-
derived growth factor alpha receptor (PDGFαR), when they also responded positive for 
NG2 (Nishiyama, Lin, Giese, Heldin, & Stallcup, 1996). As they mature into 
oligodendrocytes they gradually lose expression of NG2 antigens and enter an 
intermediate pro-oligodendrocyte stage recognized by O4 immunoreactivity, before they 
are identified as mature, fully differentiated oligodendrocyte upon detection of respective 
markers such as myelin basic protein(MBP) and myelin oligodendrocyte glycoprotein 
(MOG) (Pfeiffer, Warrington, & Bansal, 1993). Therefore in addition to O4 and 
PDGFαR, NG2 is also widely accepted as a marker for OPCs.  
Astrocytes: GFAP (glial fibrillary acidic protein) is widely used as the best marker for 
astrocytes. It was first isolated as a protein highly concentrated in old demyelinated 
plaques from multiple sclerosis patients and was found to be associated with reactive 
astrocytes in such plaques and other pathological contexts. It was later found to be an 
intermediate filament protein expressed by astrocytes in the CNS and it’s involved in the 
structure and function of cytoskeleton. In astrocytes, GFAP is thought to help maintain 
mechanical strength. Studies in transgenic mice indicated that the expression of GFAP is 
not essential for the normal appearance and function of most astrocytes, but is essential 
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for the process of reactive astrogliosis and glial scar formation (Pekny & Pekna, 2004; 
Pekny et al., 1995). However GFAP-negative mice managed to display post-traumatic 
reactive gliosis, indicating that GFAP regulation, although a hallmark for reactive gliosis, 
is not a necessity for this process (Pekny et al., 1995). 
To eliminate variation in chromagen staining across cases, for any each specific stain, 
sections from all subjects were removed from -80°C freezer at the same time, rapidly 
thawed to room temperature and batch processed all together using the same reagents for 
chromogen staining. Briefly, for each monkey 6-12 sections were pulled out at section 
intervals of approximately 1200 µm and thawed to room temperature. Prior to primary 
antibody incubation, tissue sections were rinsed to remove the glycerol and treated with 
10% hydrogen peroxide for 30 minutes to eliminate endogenous peroxidase activity. 
Sections went through blocking solution (10% normal goat serum plus 0.3% triton in 
TBS buffer) for an hour to reduce non-specific binding and background signal and were 
then incubated into primary antibody solution with 1:5000 CCR3 antibody (R&D system, 
USA), 5% NGS and 0.3% triton in TBS buffer overnight at room temperature. The next 
day tissue sections were rinsed and incubated with secondary antibody for an hour, in a 
solution consisting of 1:1000 biotinylated secondary antibody, 2.5% NGS and 0.3% triton 
in TBS buffer. Sections were then rinsed and incubated in 0.45% A/B reagent. 
Specifically, biotin was conjugated to the secondary antibody and avidin, a large 
glycoprotein that binds to biotin, can be labeled with peroxidase. DAB solution was 
activated with 0.0083% hydrogen peroxide right before reacting with tissue sections and 
then peroxidase was developed by DAB for seven minutes to produce colorimetric end 
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products. Sections were then mounted on gel-subbed slides, dried for 24 hours before 
coverslipping with permount. 
Immunofluorescence was used for double-labeling and was performed on tissue sections 
from another young animal for a qualitative analysis on CCR3-targeted cell types. Briefly, 
sections went through quenching for two hours with 0.075g/mL glycine together with 10% 
NGS and 0.3% triton, eliminating any free aldehyde groups that could non-specifically 
bind antibodies. Then for oligo fluorescence, sections were incubated with primary 
antibody solution containing 1:250 rat CCR3, 1:500 mouse CC1 and 1:250 rabbit NG2 
plus 5% NGS and 0.3% triton and microwaved twice at 250 watt, 30 ˚C for five minutes 
and continued overnight at room temperature. For astrocyte or microglia fluorescence 
procedure, in addition to CCR3, 1:500 GFAP from rabbit or 1:500 mouse LN3 and 1:500 
rabbit IBA1 were used as primary antibodies. The next day sections were incubated for 
two hours with 1:1000 goat anti rat, 1:600 goat anti mouse and 1:600 goat anti rabbit 
secondary antibodies with excitation spectrum at 488 µm, 647 µm and 568 µm 
respectively, and mounted immediately after rinse. Next, autofluorescent eliminator was 
added to the slides to eliminate lipofuscin-like autofluorescence that could potentially 
accumulate with age and affect actual fluorescent signals. The slides were then 
coverslipped in DABCo. 
All rinses consisted of five-minute incubation with TBS (pH=7.39) for three times and all 




Data collection and image analysis 
After coverslipping, slides were dried for at least 24 hours and cleaned right before 
analysis. Slides were blind coded to prevent experimenter bias. Tissue sections were 
selected from the point where corpus callosum appears anteriorly to the end of posterior 
hippocampus. For each subject five to twelve sections were processed within this range. 
For cell counting. Stereoinvestigator (SI) software from Microbrightfield Inc was used to 
map out cingulum, a collection of white matter fibers projecting from the cingulate gyrus. 
For each section, optical fractionator program on the SI program was used that is 
connected to a Nikon Eclipse E600 microscope, and the contour of ROI was outlined 
under 2x objectives. The percentage of area for counting was set at 2% and 40x 
objectives was used to make sure that there were 5-10 cells in each counting frame. Then 
a grid was generated with the overall layout of all counting frames. Cells were counted 
based on their staining intensity (cells with certain color intensity was chosen as a 
standard and any cells deeper than that get counted. The standard remained consistent 
throughout counting all subjects). Then for each section, total number of cells was 
estimated by dividing the number counted with area percentage. Finally, cell density was 
estimated based on total number of each section, area of each section and section 
intervals. 
Tissue imaging was done for densitometry analysis. In order to measure CCR3+ cell 
density in cingulate cortex, gray matter was mapped out for each section using the same 
set of slides from chromagen staining. Images were taken from anterior to posterior. 
Specifically, SRS acquired workflow on SI software was used to obtain images. Contour 
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was outlined at 2x objective on a Nikon Eclipse E600 microscope and 7% of the contour 
was randomly selected for taking image under 20x objective. Z plane for imaging was set 
where the most cells were in focus. Images where white matter occupies over 50% of the 
area were ruled out. Images were then imported into FIJI and run with a macro looking at 
percent area in the binary form indicating CCR3+ cell density, and mean density in the 
grayscale photo indicating intensity of staining in gray matter. 
Statistics 
R Studio was used for all statistical analysis. CCR3-positive cell density in cingulum, 
percent area, mean density and integrated density for CCR3-positive cells in cingulate 
cortex were calculated and run through one-way ANOVA with between group factor 
“age” (young, old) and “cognitive status” (impaired, spared), respectively. Data also went 
through two-way ANOVA with factors “gender” and “age” or “gender” and “cognitive 
status” to look at potential interaction. 
For correlation and regression, since there was only one independent variable for each 








Overview of CCR3 Expression Pattern for Each Subject 
Scatterplots show CCR3+ cell density in cingulum, percent area of staining mean staining 
intensity in cingulate cortex. Through preliminary observation there might be an increase 
in WM cell density and GM percent area staining in aged group. Effect of cognitive 
impairment on CCR3 expression level might be insignificant. Detailed analyses are 





Figure 1: Overview of CCR3 Expression Pattern for Each Subject. This figure 
shows age-related changes of CCR3+ cell density in cingulum(1A), percent area(1B) 





































Effect of Age on CCR3 Expression Level  
A two way ANOVA comparing CCR3+ cell density in cingulum (Figure 2A) with 
between-group factor “age” and within-group factor “gender” showed no significant 
difference between groups (F(8,1)=0.815, p=0.401), no significant difference between 
male and female (F(8,1)=0.073, p=0.796) and in interaction between age and gender 
(F(8,1)=0.060, p=0.815). Although there was not a significant difference with age, there 
was a trend that for aged group there were slightly more cells expressing CCR3 in 
cingulum. A two-way ANOVA comparing percent area of CCR3+ staining in cingulate 
cortex (Figure 2B) showed a significant difference between group “young” and “old” 
(F(8,1)=6.531, p=0.043), no significant difference between gender (F(8,1)=0.001. 
p=0.9752) and no interaction between age and gender (F(8,1)=1.219, p=0.3118). A two-
way ANOVA comparing CCR3+ mean staining intensity in cingulate cortex (Figure 2C) 
showed no significant difference with age (F(8,1)=0.589, p=0.472), no significant 
difference between males and females (F(8,1)=0.040, p=0.848) and no interaction 






Figure 2: Levels of CCR3 Expression with Age. Figure 2A shows stereology data of 
the number of CCR3+ cells in cingulum of young compared to old. Figure 2B and 
2C were from densitometry and Fiji for image processing. Figure 2B showed the 
proportion of area that was stained with CCR3 antibody. Figure 2C represented 
sum of grayscale value of each pixel of the image divided by number of pixels, the 
result of which showed mean staining intensity of different age groups. ANOVA 
showed that in aged group there is a significantly larger area where CCR3 is present 
(F(8,1)=6.531, p=0.043). This suggests that aged animals have more CCR3 expressed 
in cingulate cortex.  
 



































A simple linear regression model was used to correlate white matter CCR3 expression 
level with age (Figure 3A) and showed no significant correlation (R2=0.05345, 
p=0.2543). A simple linear regression model was used to correlate gray matter CCR3 
expression level with age (Figure 3B, 3C). As showed by Figure 3B, significant 
correlation was found between age and percent area of staining (R2=0.4153, p=0.0263) 
but no significant correlation was found between age and mean staining intensity (Figure 




Figure 3: Associations between Age and CCR3 Expression Level. Single linear 
models reveal that CCR3 percent area staining in gray matter is associated with age 









































We showed that more advanced age of a subject is correlated with larger proportion of 
cells in cingulate cortex that express CCR3.  
Effect of Cognitive Status on CCR3 Expression Level  
A two-way ANOVA comparing CCR3 expression level in both cingulum and cingulate 
cortex with between-group factor cognitively “impaired” versus “unimpaired” and 
within-group factor “gender” showed no significant effect of cognitive status on cell 
density in cingulum (Figure 4A, F(4,1)=1.235, p=0.382), staining percent area (Figure 4B, 
F(4,1)=1.207, p=0.387) or mean staining intensity(Figure 4C, F(4,1)=0.224, p=0.831) in 
cingulate cortex. Only data from the six aged monkeys were used in this analysis to only 
look at effect of cognitive impairment. No significant effect of gender was found on WM 
cell density (F(4,1)=0.548, p=0.536), GM percent area of staining (F(4,1)=0.049, p=0.845) 
or on GM mean staining intensity (F(4.1)=0.001, p=0.98). No interaction was found 
between gender and different cognitive status regarding WM cell density (F(4,1)=0.485, 
p=0.558), GM percent area of staining (F(4,1)=0.716, p=0.486) and GM mean staining 






Figure 4: CCR3 Expression Level in Subjects with Different Cognitive Status. 
Graphs showed number of cells expressing CCR3 in cingulum (A), CCR3 percent 
area staining (B) and mean staining intensity in cingulate cortex (C) of six aged 
monkeys that were grouped by extent of their cognitive impairment based on their 
CII scores. Two-way ANOVA shows that there is no significant difference between 
cognitively spared and impaired subjects regarding CCR3 expression level in either 
white matter or gray matter.  
Although non-significant, Figure 4A showed a tendency that subjects that were more 
cognitively impaired tend to have less CCR3 expression in cingulum. 


































To further identify cells that were stained positive for CCR3, immunofluorescence was 
performed on tissue sections from another young, unimpaired animal to double-label cells 
with CCR3 antibody and various cell markers in both gray matter and white matter. 
Figure 5A-C show labeling in gray matter under 40x with color red showing cells with 
CCR3, green for GFAP but no overlapping signals were present in the merge image. This 
means that CCR3 in gray matter may not come from astrocytes. Figure 5D-E show 
staining for CCR3 and microglia, respectively. The merged image (Figure 5F) shows no 
overlapping signals, indicating that microglia in the white matter doesn’t express CCR3. 
Figure 5G-I and Figure 5J-L show co-localization of CCR3 and mature oligodendrocytes 
or immature oligodendrocytes, respectively. Figure 5I shows very few but some 
overlapping signals while Figure 5L has much more overlapping signals, indicating while 
some mature oligodendrocytes express CCR3, the main resource of this receptor is from 
immature oligodendrocytes, or OPCs.   
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Figure 5: Immunofluorescence of CCR3 Receptor and Glial Cells. Images 
demonstrate double-labeling of CCR3 and four different markers for various type 
of glial cells. some true signals were pointed with arrowheads as examples for them 
to stand out from background signals. Each image shows the entire range of Z from 
top to bottom of the section (approximately 30µm), therefore although colors appear 
to be overlapping in Figure A-C and D-F, they are in fact present in different Z 
planes. Real co-localization was showed in Figure I and L where co-localized signals 
in merged images were represented with a different color. Purple arrowheads point 
to several cells as an example where they were stained positive for two different 
antibodies. 
Here we demonstrate that presence of CCR3 in gray matter is mainly from neurons not 











Chemokines were previously shown to be elevated in the serum and CSF during aging 
and produced by activated glial cells in process of neuroinflammation in AD brain (Choi 
et al., 2008; Leung et al., 2013; Soares et al., 2012). In this preliminary study we 
investigated the general role of C-C chemokine receptor type 3 (CCR3) in normal aging 
rhesus monkey brains by measuring CCR3 expression level in the white matter of the 
cingulum and the gray matter of cingulate cortex. Our previous findings demonstrate that 
clearance of damaged myelin may be impaired in aging and cognitive decline as a result 
of microglia becoming dysfunctional with age and OPCs being halted in their normal 
function (Shobin Eli, 2018). In addition, in healthy aging myelin debris are effectively 
removed whereas in cognitively impaired agers myelin debris remains in the brain, 
causing further damage (Shobin Eli, 2018). In the present study, histological examination 
of CCR3 level in young adult and aged rhesus monkeys reveals that (1) in aged subjects 
there is a significant increase in number of cells in cingulate cortex that express CCR3. 
Additionally, the increase followed a linear regression model and correlated with age. (2) 
Although not significant, there was a trend for aged subjects to have more cells in white 
matter that express CCR3 and a trend that cognitively impaired agers tend to have smaller 
number of CCR3+ cells. (3) In young adult monkey brain, oligodendrocyte precursor 
cells are the primary source of CCR3 in white matter.  
Correlation between Gray Matter CCR3 Increase and Aging  
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In the present study we showed an age-related increase in number of cells expressing 
CCR3 in cingulate cortex. While the amount of CCR3 per cell remains not significantly 
different, we could postulate an overall increasing amount of CCR3 in cingulate cortex 
during aging. Although simply based on present data it remains unknown whether the 
increasing amount of CCR3 facilitates aging process or it is part of aging pathology, 
another in vitro study has found the interaction between CCR3 and CCL11 to be involved 
in the production of Aβ and dendritic spine loss in AD pathogenesis in that these effects 
could be blocked by CCR3 specific antagonist (Zhu, Xu, Sun, Zhu, & Sui, 2017) 
suggesting a causative effect of CCR3 on neuroinflammation.  
Two more recent studies have pointed to a pro-disease effect of CCR3. In 2016 Zhang et 
al used mouse cortical culture and found that inhibition of CCR3 provides protection 
from cell death caused by ischemia and glucose deprivation, therefore identified CCR3 as 
a mediator for neuronal death (Zhang et al., 2016); Ahmad et al treated BTBR mice with 
CGS, A2A receptor agonist, and found a decrease in C-C chemokine receptor signaling. 
A2A is known to have neuroprotective, immunomodulatory and analgesic properties and 
its down-regulation of chemokine receptor signaling pathways indicate receptors 
including CCR3 might facilitate progression of neuroimmunological diseases (Ahmad et 
al., 2018). Indeed substantial evidence pointed to the interaction and crosstalk between T 
cell immune system and CNS. The role of T cells on CNS could be both beneficial and 
pathologic (Anderson et al., 2014; Olson & Gendelman, 2016; Yshii, Gebauer, Bernard-
Valnet, & Liblau, 2015), and CNS itself can also induce changes in the immune system 
via neuro-endocrine-immune network (Hirokawa, Utsuyama, & Kobayashi, 1998; 
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Procaccini, Pucino, De Rosa, Marone, & Matarese, 2014; Tanriverdi, Silveira, MacColl, 
& Bouloux, 2003). Thymus, central organ of the T cell immune system, also undergoes 
natural aging process characterized by involution resulting in autoreactive T-cells altering 
permeability of BBB and attacking choroid plexus (Kunis et al., 2013; Schwartz & 
Baruch, 2014; Shechter, London, & Schwartz, 2013), the two major paths by which 
CCL11 enters the brain. Our current result that aged monkeys have an increase in amount 
of CCR3 is in accordance with these above-mentioned findings, meanwhile specifically 
underlines the significance of CCR3 and puts forward the potential role of CCR3 in 
immune system – CNS interaction.  
Limitations 
Although there has been substantial evidence from our previous study that myelin 
damage and other shite matter pathologies are key to cognitive impairment along with 
normal aging progression, current study failed to identify any significant changes in 
CCR3 level in white matter either with different age groups or various extent of cognitive 
impairment. It is possible that (1) amount of CCR3 simply is not altered or (2) its role 
failed to be demonstrated due to small sample size, relatively large within-group 
variation, difference in tissue processing and complicated background of individual 
subjects. For example, one old impaired subject (AM180) and two young unimpaired 
subject (AM188, AM205) was perfused only with 4% paraformaldehyde while the rest 
went through Kreb-Henseleit solution first for ten minutes in which case cells are 
exposed to prolonged anoxia and potentially more prone to cell stress. While AM180 
showed a relatively lower level of CCR3 in white matter compared to other aged 
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subjects, CCR3 level of the two young subjects remain within the range of other young 
ones. If CCR3 were to be involved in white matter pathology during aging, AM180, 
being more sensitive to cell stress, could possess a smaller amount of CCR3 compared to 
reality where it was perfused with paraformaldehyde ten minutes later.  In addition, 
another old subject (AM301) was tested cognitively spared (CII: 1.14) yet had the highest 
number in WM CCR3+ cell density. He had a history of diabetes and had been treated 
with resveratrol, which is known to have effective antioxidant and anti-inflammatory 
function. This could help with his cognition to the extent that balances out the adverse 
impact CCR3 possibly has on cognitive function. Considering the limited sample size, 
although these variations are individual, they could still have a specific but profound 
influence on some of the results.  
In summary, although current study failed to demonstrate significant changes in white 
matter CCR3 expression level, considering the aforementioned limitations, we couldn’t 
deny the potential role of CCR3 in white matter pathology involved in normal cognitive 
aging. 
Conclusion 
Aging is accompanied with volume loss of both gray matter and white matter in the CNS. 
Ever since Villeda et al found injection of CCL11 into (Villeda et al., 2010) young mouse 
brain resulted in memory impairment and inhibition of neurogenesis, numerous studies 
have identified it to be pro-inflammatory. However, through which pathway does CCL11 
“talk” to resident cells in brain and to invoke such changes remained unknown. As our 
previous findings attribute age-related cognitive impairment to white matter pathology, 
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this study focuses on CCR3 whose expression was found to be active but highly regulated 
in mouse brain, uses a more translational animal model and tries to illustrate CCR3’s 
involvement in our existing aging model and other hypotheses. Specifically, we found in 
this study that there is an increasing amount of CCR3 in gray matter with age. Although 
such increase was not observed in white matter, nor did we find significant changes in 
CCR3 with cognitive impairment, we did identify OPCs as a crucial resource of CCR3 
After OPCs develop into mature oligodendrocyte, CCR3 expression wasn’t observable. 
Due to the limited sample size, background variability of our subjects and the unique 
expression pattern by OPCs, it’s possible that CCR3 is involved in white matter aging 
pathology. Therefore it is necessary for future research to include larger sample size, to 
further assess changes in types of cells that express CCR3 along with age, and to 
investigate level of CCL11 in gray matter and the change of CCL11-CCR3 interaction 
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